Packaging, Leaflets and User Instructions for Safe OTC Use Packaging, Leaflets and User Instructions for Safe OTC Use The regulatory landscape for Over-The-Counter (OTC) products has continually evolved, bringing forth challenges and opportunities for pharmaceutical and biotechnology companies. Understanding the regulatory affairs compliance requirements is crucial not only for successful product development but also for ensuring consumer safety and product efficacy in the marketplace. This article aims to provide a comprehensive overview of packaging, leaflets, and user instructions for OTC products, specifically addressing regulatory guidelines, legal bases, documentation requirements, review and approval processes, and common deficiencies that may arise during…

Regulatory Interfaces Between OTC Medicines, Supplements and Devices Regulatory Interfaces Between OTC Medicines, Supplements and Devices The landscape of healthcare products is evolving rapidly, fueled by scientific advancements and an increasing demand for accessible therapies. As a result, the regulatory affairs arena requires keen insights into the nuanced distinctions and interfacial spaces between Over-The-Counter (OTC) medicines, dietary supplements, and medical devices. This article aims to serve as a comprehensive manual for regulatory affairs professionals, particularly those involved in the development, marketing, and compliance of these special product categories across the US, UK, and EU. Context Regulatory frameworks governing OTC medicines,…

Switch Feasibility Assessments: When Is a Product a Good OTC Candidate? Switch Feasibility Assessments: When Is a Product a Good OTC Candidate? The transition of a pharmaceutical product from prescription (Rx) to over-the-counter (OTC) status involves a comprehensive regulatory assessment. Regulatory Affairs professionals must navigate the complex landscape of guidelines and regulations to determine whether a product qualifies for an OTC switch. This article aims to provide an in-depth understanding of the regulatory processes, considerations, and documentation necessary for a successful switch feasibility assessment. Regulatory Context The classification of a product as an OTC involves significant regulatory scrutiny. In the…

Benefit–Risk Assessment in Self-Medication and Consumer Health Environments Benefit–Risk Assessment in Self-Medication and Consumer Health Environments In the rapidly evolving landscape of consumer health, the role of pharmacovigilance has become increasingly pivotal. As various product categories transition from prescription (Rx) to over-the-counter (OTC) status, a comprehensive understanding of benefit–risk assessment in these new frameworks is essential for Regulatory Affairs professionals. This article provides a detailed exploration of the regulatory expectations, guidelines, and common deficiencies associated with this evolution within the context of the US, EU, and UK regulations. Context Self-medication is a growing trend where consumers opt for OTC products…

Responding to Safety Concerns and Media Scrutiny for OTC Categories Responding to Safety Concerns and Media Scrutiny for OTC Categories The landscape of regulatory affairs is becoming increasingly complex, particularly for over-the-counter (OTC) products that face intense scrutiny from both regulatory agencies and the media. This article serves as a comprehensive guide for professionals in Regulatory Affairs (RA), Chemistry, Manufacturing, and Controls (CMC), and Labelling teams within the pharmaceutical and biotech industries in the US, UK, and EU regions. The focus will be on the frameworks governing OTC products, especially in relation to safety concerns and public perception, along with…

Engaging with Regulators on Novel Self-Care and Digital Health OTC Models Engaging with Regulators on Novel Self-Care and Digital Health OTC Models Context Novel self-care initiatives, particularly in the context of Over-The-Counter (OTC) products, are gaining traction across global markets, especially within the US, EU, and UK jurisdictions. The integration of digital health technologies, such as mobile health applications and telehealth services, with OTC products presents unique regulatory challenges and opportunities for pharmaceutical and biotech companies. Understanding the regulatory landscape governing these products, including expectations for pharmacovigilance systems, is crucial for ensuring compliance and market success. Legal/Regulatory Basis In both…

Aligning OTC Regulatory Strategy with Market Access and Category Management Aligning OTC Regulatory Strategy with Market Access and Category Management In the ever-evolving landscape of pharmaceutical regulations, aligning over-the-counter (OTC) regulatory strategies with market access and category management is critical for achieving successful product commercialization. This article aims to provide a comprehensive overview of the pertinent regulations, guidelines, and agency expectations governing OTC products, while emphasizing the interconnections between Regulatory Affairs, Chemistry, Manufacturing and Controls (CMC), Clinical, Pharmacovigilance (PV), Quality Assurance (QA), and Commercial teams. Context OTC products play a vital role in healthcare by allowing consumers to self-manage certain…

Templates for Rx-to-OTC Switch Dossiers and Study Designs Templates for Rx-to-OTC Switch Dossiers and Study Designs The process of switching a product from prescription (Rx) to over-the-counter (OTC) status is a critical pathway within regulatory affairs, enabling broader consumer access to certain medications. Understanding the nuanced requirements for establishing regulatory compliance is essential for pharmaceutical companies navigating this complex landscape. This article provides a structured exploration of the regulatory environment, necessary documentation, review processes, and best practices pertaining to Rx-to-OTC switches in the US, UK, and EU. Context of Rx-to-OTC Switches Rx-to-OTC switches are a significant segment of the pharmaceutical…

Global Trends in OTC Regulation and Self-Care Policy Global Trends in OTC Regulation and Self-Care Policy The regulatory landscape surrounding Over-the-Counter (OTC) products and self-care policies is evolving rapidly in the US, EU, and UK. Advances in regulatory science, alongside increasing consumer demand for accessible healthcare solutions, have led regulatory agencies to rethink their frameworks around self-care and OTC products. This article serves as an in-depth regulatory explainer manual, guiding Regulatory Affairs (RA), CMC, and Labelling teams through the relevant regulations, guidelines, and agency expectations. Regulatory Context OTC products, defined as medicines available without a prescription, have come to symbolize…

Future of Consumer Health: Digital Tools, Apps and Connected Devices Future of Consumer Health: Digital Tools, Apps and Connected Devices Regulatory Affairs Context The transition from prescription medications to over-the-counter (OTC) options is increasingly influenced by advancing digital tools, applications, and connected devices. This shift emphasizes the importance of Regulatory Affairs (RA) in ensuring compliance with legal standards while facilitating innovation in consumer health. RA professionals must navigate various regulatory frameworks in the US (FDA), EU (EMA), and UK (MHRA) as these technologies redefine the landscape of OTC products. Legal/Regulatory Basis The regulations governing consumer health products, particularly those that…